Fresenius Kabi’s US Sales Drop 10% As COVID-19 Hits Demand
Company Plans Six Launches And Investment In US Manufacturing
Executive Summary
Fresenius Kabi has announced plans for six new launches along with fresh investment in manufacturing in the US market after the firm saw a 10% drop in North American sales in the third quarter. However, the company’s business in China saw a “solid recovery” to “pre-pandemic levels.”